PharmacoEconomics & Outcomes News

, Volume 799, Issue 1, pp 5–5 | Cite as

ICER: prostate cancer, amyloidosis treatments up for comment

News item


  1. Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Requests Public Comment on Two Draft Scoping Documents: Treatments for High-Risk Prostate Cancer and Amyloidosis. Internet Document : 12 Mar 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations